When Should a DMC Be Established in a Cancer Trial?
A DMC should be established before the initiation of the trial. This ensures that there is a mechanism in place from the start to monitor patient safety and treatment efficacy. The need for a DMC is particularly critical in phase III trials, but it can also be beneficial in earlier phases, especially for high-risk or novel therapies.
